Chimin Health Management Co., Ltd. (603222.SS)
CNY 7.56
(-1.18%)
CNY 7.56
(-1.18%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 84.09 Million CNY | -21.64% |
| 2022 | 154.53 Million CNY | -41.26% |
| 2021 | 295.24 Million CNY | 111.4% |
| 2020 | 118.92 Million CNY | -9.64% |
| 2019 | 193.64 Million CNY | 54.34% |
| 2018 | 119.56 Million CNY | -2.3% |
| 2017 | 120.2 Million CNY | 54.35% |
| 2016 | 80.76 Million CNY | -15.76% |
| 2015 | 89.82 Million CNY | -8.47% |
| 2014 | 101.04 Million CNY | -22.61% |
| 2013 | 128.57 Million CNY | 11.06% |
| 2012 | 119.65 Million CNY | -4.12% |
| 2011 | 123.1 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 24.86 Million CNY | 162.08% |
| 2024 Q2 | 18.29 Million CNY | -61.28% |
| 2024 Q3 | 7.22 Million CNY | -60.51% |
| 2023 Q1 | 48.69 Million CNY | 268.59% |
| 2023 Q2 | 16.5 Million CNY | -66.11% |
| 2023 Q3 | 18.64 Million CNY | 12.97% |
| 2023 Q4 | -25.03 Million CNY | -234.26% |
| 2023 FY | - CNY | -21.64% |
| 2022 Q2 | -8.84 Million CNY | -109.48% |
| 2022 Q1 | 93.35 Million CNY | 57.87% |
| 2022 FY | - CNY | -41.26% |
| 2022 Q4 | 13.21 Million CNY | -47.53% |
| 2022 Q3 | 25.17 Million CNY | 384.51% |
| 2021 Q3 | 55.42 Million CNY | -39.2% |
| 2021 Q4 | 59.13 Million CNY | 6.69% |
| 2021 FY | - CNY | 111.4% |
| 2021 Q2 | 91.16 Million CNY | 48.81% |
| 2021 Q1 | 61.26 Million CNY | 86.79% |
| 2020 Q4 | 32.79 Million CNY | -38.72% |
| 2020 FY | - CNY | -9.64% |
| 2020 Q1 | -5.51 Million CNY | -121.05% |
| 2020 Q2 | 15.17 Million CNY | 374.95% |
| 2020 Q3 | 53.51 Million CNY | 252.77% |
| 2019 Q2 | 31.66 Million CNY | 16.9% |
| 2019 FY | - CNY | 54.34% |
| 2019 Q1 | 27.09 Million CNY | 334.59% |
| 2019 Q3 | 33.16 Million CNY | 4.73% |
| 2019 Q4 | 26.21 Million CNY | -20.97% |
| 2018 Q4 | -11.54 Million CNY | -149.76% |
| 2018 Q3 | 23.2 Million CNY | -24.54% |
| 2018 Q2 | 30.75 Million CNY | 10.46% |
| 2018 Q1 | 27.83 Million CNY | 79.4% |
| 2018 FY | - CNY | -2.3% |
| 2017 FY | - CNY | 54.35% |
| 2017 Q4 | 15.51 Million CNY | -52.76% |
| 2017 Q3 | 32.84 Million CNY | 105.64% |
| 2017 Q1 | 18.21 Million CNY | 7.97% |
| 2017 Q2 | 15.97 Million CNY | -12.33% |
| 2016 Q1 | 9.35 Million CNY | -35.29% |
| 2016 Q3 | 15.74 Million CNY | 151.58% |
| 2016 Q4 | 16.87 Million CNY | 7.19% |
| 2016 Q2 | 6.25 Million CNY | -33.13% |
| 2016 FY | - CNY | -15.76% |
| 2015 Q1 | 20.48 Million CNY | -17.54% |
| 2015 Q2 | 9.06 Million CNY | -55.75% |
| 2015 Q3 | 18.72 Million CNY | 106.62% |
| 2015 Q4 | 14.46 Million CNY | -22.78% |
| 2015 FY | - CNY | -8.47% |
| 2014 Q3 | 26.02 Million CNY | 30.81% |
| 2014 Q4 | 24.84 Million CNY | -4.55% |
| 2014 Q1 | 16.52 Million CNY | 0.0% |
| 2014 FY | - CNY | -22.61% |
| 2014 Q2 | 19.89 Million CNY | 20.37% |
| 2013 FY | - CNY | 11.06% |
| 2012 FY | - CNY | -4.12% |
| 2011 FY | - CNY | 0.0% |